Amdocs (NASDAQ:DOX) Releases Q4 2025 Earnings Guidance

Key Points

• Amdocs has issued Q4 2025 earnings guidance with an expected earnings per share of 1.790-1.850 and revenue guidance of $1.1 billion-$1.2 billion, both of which are slightly above analysts' estimates.
• As of the latest trading session, Amdocs shares have risen to $87.68, with a market capitalization of approximately $9.90 billion and a PE ratio of 18.58.
• Amdocs received mixed analyst ratings, with one report downgrading the stock from "buy" to "hold," while four analysts maintain a buy rating, resulting in a consensus rating of "Moderate Buy".

Amdocs (NASDAQ:DOX - Get Free Report) issued an update on its fourth quarter 2025 earnings guidance on Thursday morning. The company provided EPS guidance of 1.790-1.850 for the period, compared to the consensus EPS estimate of 1.823. The company issued revenue guidance of $1.1 billion-$1.2 billion, compared to the consensus revenue estimate of $1.1 billion. Amdocs also updated its FY 2025 guidance to 6.960-7.020 EPS.

Amdocs Price Performance

Shares of Amdocs stock traded down $2.96 on Monday, reaching $86.45. The company's stock had a trading volume of 1,154,551 shares, compared to its average volume of 712,101. The company has a market capitalization of $9.76 billion, a P/E ratio of 17.54, a PEG ratio of 1.64 and a beta of 0.51. Amdocs has a 52-week low of $78.61 and a 52-week high of $95.41. The stock has a 50-day moving average price of $90.17 and a 200-day moving average price of $88.77. The company has a quick ratio of 1.16, a current ratio of 1.22 and a debt-to-equity ratio of 0.23.

Amdocs (NASDAQ:DOX - Get Free Report) last issued its quarterly earnings results on Wednesday, August 6th. The technology company reported $1.72 EPS for the quarter, topping the consensus estimate of $1.71 by $0.01. Amdocs had a return on equity of 19.66% and a net margin of 11.94%. The firm had revenue of $1.14 billion during the quarter, compared to analysts' expectations of $1.13 billion. During the same period in the previous year, the business earned $1.62 earnings per share. The firm's revenue for the quarter was down 8.4% on a year-over-year basis. Analysts expect that Amdocs will post 6.21 EPS for the current year.

Amdocs Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be issued a $0.527 dividend. This represents a $2.11 annualized dividend and a yield of 2.4%. The ex-dividend date is Tuesday, September 30th. Amdocs's dividend payout ratio is presently 42.60%.

Analysts Set New Price Targets

Several analysts have issued reports on the company. Wall Street Zen upgraded Amdocs from a "hold" rating to a "buy" rating in a report on Sunday. Wolfe Research assumed coverage on Amdocs in a report on Tuesday, July 8th. They issued an "outperform" rating for the company. Five research analysts have rated the stock with a buy rating, Based on data from MarketBeat, Amdocs has a consensus rating of "Buy" and an average price target of $105.33.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Geneos Wealth Management Inc. boosted its stake in shares of Amdocs by 213.9% in the 1st quarter. Geneos Wealth Management Inc. now owns 700 shares of the technology company's stock valued at $64,000 after buying an additional 477 shares during the period. Amundi raised its position in shares of Amdocs by 73.0% during the 1st quarter. Amundi now owns 13,778 shares of the technology company's stock worth $1,217,000 after acquiring an additional 5,816 shares in the last quarter. Empowered Funds LLC raised its position in shares of Amdocs by 12.0% during the 1st quarter. Empowered Funds LLC now owns 15,979 shares of the technology company's stock worth $1,462,000 after acquiring an additional 1,709 shares in the last quarter. Millennium Management LLC raised its position in shares of Amdocs by 458.3% during the 1st quarter. Millennium Management LLC now owns 67,047 shares of the technology company's stock worth $6,135,000 after acquiring an additional 55,038 shares in the last quarter. Finally, Jane Street Group LLC raised its position in shares of Amdocs by 195.4% during the 1st quarter. Jane Street Group LLC now owns 115,929 shares of the technology company's stock worth $10,608,000 after acquiring an additional 76,683 shares in the last quarter. Institutional investors and hedge funds own 92.02% of the company's stock.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.